An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
Alison C West, Stephen R Mattarollo, Jake Shortt, Leonie A Cluse, Ailsa J Christiansen, Mark J Smyth, Ricky W Johnstone
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2013
This work was supported by a Program grant from the National Health and Medical Research Council (NHMRC). A.C. West and A.J. Christiansen were supported by Cancer Council of Victoria (CCV) Fellowships, S.R. Mattarollo was supported by a Balzan Foundation Fellowship. M.J. Smyth was supported by an NHMRC Australia Fellowship, and R.W. Johnstone was supported by an NHMRC Principal Research Fellowship, CCV, The Leukaemia Foundation of Australia, the Victorian Breast Cancer Research Consortium, and the Victorian Cancer Agency.